IRIS Accounts Production v25.1.4.42 SC417669 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC4176692024-03-31SC4176692025-03-31SC4176692024-04-012025-03-31SC4176692023-03-31SC4176692023-04-012024-03-31SC4176692024-03-31SC417669ns15:Scotland2024-04-012025-03-31SC417669ns14:PoundSterling2024-04-012025-03-31SC417669ns10:Director12024-04-012025-03-31SC417669ns10:PrivateLimitedCompanyLtd2024-04-012025-03-31SC417669ns10:SmallEntities2024-04-012025-03-31SC417669ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-31SC417669ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-31SC417669ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-31SC417669ns10:FullAccounts2024-04-012025-03-31SC417669ns10:Director22024-04-012025-03-31SC417669ns10:RegisteredOffice2024-04-012025-03-31SC417669ns5:CurrentFinancialInstruments2025-03-31SC417669ns5:CurrentFinancialInstruments2024-03-31SC417669ns5:Non-currentFinancialInstruments2025-03-31SC417669ns5:Non-currentFinancialInstruments2024-03-31SC417669ns5:ShareCapital2025-03-31SC417669ns5:ShareCapital2024-03-31SC417669ns5:RetainedEarningsAccumulatedLosses2025-03-31SC417669ns5:RetainedEarningsAccumulatedLosses2024-03-31SC417669ns5:FurnitureFittings2024-04-012025-03-31SC417669ns5:MotorVehicles2024-04-012025-03-31SC417669ns5:FurnitureFittings2024-03-31SC417669ns5:MotorVehicles2024-03-31SC417669ns5:FurnitureFittings2025-03-31SC417669ns5:MotorVehicles2025-03-31SC417669ns5:FurnitureFittings2024-03-31SC417669ns5:MotorVehicles2024-03-31SC417669ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-31SC417669ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-31
REGISTERED NUMBER: SC417669 (Scotland)












Unaudited Financial Statements

for the Year Ended 31 March 2025

for

Crail Pharmacy Limited

Crail Pharmacy Limited (Registered number: SC417669)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Crail Pharmacy Limited

Company Information
for the Year Ended 31 March 2025







DIRECTORS: Mrs L A Rooney
Mr I F Rooney





REGISTERED OFFICE: 28 Rodger Street
Anstruther
Fife
KY10 3DU





REGISTERED NUMBER: SC417669 (Scotland)





ACCOUNTANTS: Henderson Black & Co
Chartered Accountants
28 Rodger Street
Anstruther
Fife
KY10 3DU

Crail Pharmacy Limited (Registered number: SC417669)

Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 38,926 43,357

CURRENT ASSETS
Stocks 43,124 37,090
Debtors 5 73,672 64,659
Cash at bank and in hand 80,069 71,886
196,865 173,635
CREDITORS
Amounts falling due within one year 6 155,308 140,196
NET CURRENT ASSETS 41,557 33,439
TOTAL ASSETS LESS CURRENT
LIABILITIES

80,483

76,796

CREDITORS
Amounts falling due after more than one
year

7

(11,408

)

(15,929

)

PROVISIONS FOR LIABILITIES (4,184 ) (4,074 )
NET ASSETS 64,891 56,793

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Retained earnings 63,891 55,793
SHAREHOLDERS' FUNDS 64,891 56,793

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Crail Pharmacy Limited (Registered number: SC417669)

Balance Sheet - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 25 June 2025 and were signed on its behalf by:





Mr I F Rooney - Director


Crail Pharmacy Limited (Registered number: SC417669)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Crail Pharmacy Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
In the application of the company's accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily available from other sources. The estimates and associated assumptions are based on historical experience and other factors that are to be relevant. Actual results may differ from these estimates. In preparing these financial statements, the director has made the following judgements:

Accruals
The director estimates the requirements for accruals using post year end information. This identifies costs that are expected to be incurred for services provided by other parties. Accruals are only released when there is a reasonable expectation that these costs will not be invoiced in the future.

Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on cost
Motor vehicles - 25% on reducing balance

Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in the profit and loss account. Reversals of impairment losses are also recognised in the profit and loss account.


Crail Pharmacy Limited (Registered number: SC417669)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

Crail Pharmacy Limited (Registered number: SC417669)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued

Financial instruments
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities
Basic financial liabilities
Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less, recognised at transaction price.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2024 - 4 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Motor
fittings vehicles Totals
£    £    £   
COST
At 1 April 2024 13,425 67,000 80,425
Additions 7,287 - 7,287
At 31 March 2025 20,712 67,000 87,712
DEPRECIATION
At 1 April 2024 9,162 27,906 37,068
Charge for year 1,944 9,774 11,718
At 31 March 2025 11,106 37,680 48,786
NET BOOK VALUE
At 31 March 2025 9,606 29,320 38,926
At 31 March 2024 4,263 39,094 43,357

Crail Pharmacy Limited (Registered number: SC417669)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 51,714 42,965
Other debtors 21,958 21,694
73,672 64,659

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Hire purchase contracts 4,522 4,052
Trade creditors 67,920 55,743
Taxation and social security 37,043 39,674
Other creditors 45,823 40,727
155,308 140,196

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.3.25 31.3.24
£    £   
Hire purchase contracts 11,408 15,929

8. FLOATING CHARGE

Unity bank hold a floating charge over the assets of the company.